200 related articles for article (PubMed ID: 16524383)
21. Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
Hirohata M; Ono K; Naiki H; Yamada M
Neuropharmacology; 2005 Dec; 49(7):1088-99. PubMed ID: 16125740
[TBL] [Abstract][Full Text] [Related]
22. Fibrillogenic and non-fibrillogenic ensembles of SDS-bound human alpha-synuclein.
Ahmad MF; Ramakrishna T; Raman B; Rao ChM
J Mol Biol; 2006 Dec; 364(5):1061-72. PubMed ID: 17054982
[TBL] [Abstract][Full Text] [Related]
23. Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds.
Caruana M; Högen T; Levin J; Hillmer A; Giese A; Vassallo N
FEBS Lett; 2011 Apr; 585(8):1113-20. PubMed ID: 21443877
[TBL] [Abstract][Full Text] [Related]
24. Blood-borne factors inhibit Alzheimer's beta-amyloid fibril formation in vitro.
Ono K; Noguchi-Shinohara M; Samuraki M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M
Exp Neurol; 2006 Nov; 202(1):125-32. PubMed ID: 16806179
[TBL] [Abstract][Full Text] [Related]
25. Estrogen has anti-amyloidogenic effects on Alzheimer's beta-amyloid fibrils in vitro.
Morinaga A; Hirohata M; Ono K; Yamada M
Biochem Biophys Res Commun; 2007 Aug; 359(3):697-702. PubMed ID: 17559807
[TBL] [Abstract][Full Text] [Related]
26. Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro.
Ono K; Takasaki J; Takahashi R; Ikeda T; Yamada M
J Neurosci Res; 2013 Oct; 91(10):1371-81. PubMed ID: 23913715
[TBL] [Abstract][Full Text] [Related]
27. Anti-amyloidogenic activity of S-allyl-L-cysteine and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro.
Gupta VB; Rao KS
Neurosci Lett; 2007 Dec; 429(2-3):75-80. PubMed ID: 18023978
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells.
Hossain S; Hashimoto M; Katakura M; Miwa K; Shimada T; Shido O
J Neurochem; 2009 Oct; 111(2):568-79. PubMed ID: 19686246
[TBL] [Abstract][Full Text] [Related]
29. In vitro evidence that an aqueous extract of Centella asiatica modulates α-synuclein aggregation dynamics.
Berrocal R; Vasudevaraju P; Indi SS; Sambasiva Rao KR; Rao KS
J Alzheimers Dis; 2014; 39(2):457-65. PubMed ID: 24284367
[TBL] [Abstract][Full Text] [Related]
30. beta-Sheet-breaking peptides inhibit the fibrillation of human alpha-synuclein.
Kim YS; Lim D; Kim JY; Kang SJ; Kim YH; Im H
Biochem Biophys Res Commun; 2009 Oct; 387(4):682-7. PubMed ID: 19622344
[TBL] [Abstract][Full Text] [Related]
31. Characterization of fibrillation process of alpha-synuclein at the initial stage.
Tashiro M; Kojima M; Kihara H; Kasai K; Kamiyoshihara T; Uéda K; Shimotakahara S
Biochem Biophys Res Commun; 2008 May; 369(3):910-4. PubMed ID: 18329380
[TBL] [Abstract][Full Text] [Related]
32. In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
Fodero-Tavoletti MT; Mulligan RS; Okamura N; Furumoto S; Rowe CC; Kudo Y; Masters CL; Cappai R; Yanai K; Villemagne VL
Eur J Pharmacol; 2009 Sep; 617(1-3):54-8. PubMed ID: 19576880
[TBL] [Abstract][Full Text] [Related]
33. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization.
Bosco DA; Fowler DM; Zhang Q; Nieva J; Powers ET; Wentworth P; Lerner RA; Kelly JW
Nat Chem Biol; 2006 May; 2(5):249-53. PubMed ID: 16565714
[TBL] [Abstract][Full Text] [Related]
34. Effects of saffron and its constituents, crocin-1, crocin-2, and crocetin on α-synuclein fibrils.
Inoue E; Shimizu Y; Masui R; Hayakawa T; Tsubonoya T; Hori S; Sudoh K
J Nat Med; 2018 Jan; 72(1):274-279. PubMed ID: 29147836
[TBL] [Abstract][Full Text] [Related]
35. The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure.
Hirohata M; Hasegawa K; Tsutsumi-Yasuhara S; Ohhashi Y; Ookoshi T; Ono K; Yamada M; Naiki H
Biochemistry; 2007 Feb; 46(7):1888-99. PubMed ID: 17253770
[TBL] [Abstract][Full Text] [Related]
36. Curcumin inhibits aggregation of alpha-synuclein.
Pandey N; Strider J; Nolan WC; Yan SX; Galvin JE
Acta Neuropathol; 2008 Apr; 115(4):479-89. PubMed ID: 18189141
[TBL] [Abstract][Full Text] [Related]
37. Sensitive fluorescence polarization technique for rapid screening of alpha-synuclein oligomerization/fibrillization inhibitors.
Luk KC; Hyde EG; Trojanowski JQ; Lee VM
Biochemistry; 2007 Nov; 46(44):12522-9. PubMed ID: 17927212
[TBL] [Abstract][Full Text] [Related]
38. Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synuclein.
Kobayashi M; Kim J; Kobayashi N; Han S; Nakamura C; Ikebukuro K; Sode K
Biochem Biophys Res Commun; 2006 Oct; 349(3):1139-44. PubMed ID: 16962995
[TBL] [Abstract][Full Text] [Related]
39. Observation of multiple intermediates in alpha-synuclein fibril formation by singular value decomposition analysis.
Kamiyoshihara T; Kojima M; Uéda K; Tashiro M; Shimotakahara S
Biochem Biophys Res Commun; 2007 Apr; 355(2):398-403. PubMed ID: 17300751
[TBL] [Abstract][Full Text] [Related]
40. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]